Heparin-induced thrombocytopenia - Veralox Therapeutics

About Veralox
- Meet the Team
Our Approach
Pipeline
- Publications
Company News
Contact

Search for:

Publications & Presentations

August 11, 2022

Heparin-induced thrombocytopenia

Visit Publication

Share Article

Facebook
Twitter
LinkedIn
Email

Developing new therapies for life-threatening immuno-inflammatory diseases

Veralox Headquarters

321 Ballenger Center Dr
Suite 125
Frederick, MD 21703

About Veralox
Our Approach
Pipeline
Team
Publications
Company News
Contact

Copyright 2024 | Website design by Celerate.